Double Blind, Placebo-Controlled, Randomised Investigation of Ondansetron in Schizophrenia
Clinical trial NCT01121042 · COMPLETED
Trial details
- NCT number
- NCT01121042
- Sponsor
- Bayside Health
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2018-08-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.